Bank of America
DNA icon

Bank of America’s Ginkgo Bioworks DNA Stock Holding History

Bank of America’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.41M Buy
545,852
+68,939
+14% +$577K ﹤0.01% 3503
2026
Q1 		$2.92M Sell
476,913
-125,663
-21% -$1.05M ﹤0.01% 3850
2025
Q4 		$5.01M Sell
602,576
-465,999
-44% -$5.02M ﹤0.01% 3393
2025
Q3 		$15.6M Sell
1,068,575
-138,572
-11% -$1.66M ﹤0.01% 2846
2025
Q2 		$13.6M Buy
1,207,147
+199,813
+20% +$1.55M ﹤0.01% 2940
2025
Q1 		$5.74M Sell
1,007,334
-2,757,121
-73% -$28.1M ﹤0.01% 3670
2024
Q4 		$37M Buy
3,764,455
+3,336,964
+781% +$28.6M ﹤0.01% 1757
2024
Q3 		$3.48M Buy
427,491
+358,770
+522% +$3.59M ﹤0.01% 4074
2024
Q2 		$918K Sell
68,721
-9,210
-12% -$275K ﹤0.01% 4956
2024
Q1 		$3.62M Buy
77,931
+15,478
+25% +$801K ﹤0.01% 3934
2023
Q4 		$4.22M Sell
62,453
-4,894
-7% -$300K ﹤0.01% 3686
2023
Q3 		$4.88M Buy
67,347
+1,521
+2% +$122K ﹤0.01% 3431
2023
Q2 		$4.9M Buy
65,826
+2,906
+5% +$172K ﹤0.01% 3430
2023
Q1 		$3.35M Buy
62,920
+7,459
+13% +$473K ﹤0.01% 3908
2022
Q4 		$3.75M Sell
55,461
-14,747
-21% -$1.36M ﹤0.01% 3668
2022
Q3 		$8.76M Buy
70,208
+15,141
+27% +$1.8M ﹤0.01% 2747
2022
Q2 		$5.24M Sell
55,067
-11,406
-17% -$1.39M ﹤0.01% 3335
2022
Q1 		$10.7M Buy
66,473
+36,878
+125% +$7.18M ﹤0.01% 2800
2021
Q4 		$9.84M Buy
29,595
+27,414
+1,257% +$13M ﹤0.01% 2950
2021
Q3 		$1.01M Buy
+2,181
New +$1.06M ﹤0.01% 5056

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Bank of America's DNA Position: Q2 2026 in Review

Bank of America increased its Ginkgo Bioworks (DNA) stake by 14% in Q2 2026, buying an estimated $577K and bringing the position to 545,852 shares worth $5.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3503.

Bank of America first reported a position in DNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $37M in Q4 2024. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Bank of America held 545,852 shares of Ginkgo Bioworks worth $5.41M as of Q2 2026.
  • Bank of America bought 68,939 Ginkgo Bioworks shares in Q2 2026, an estimated $577K.
  • Ginkgo Bioworks made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #3503 holding.
  • Bank of America first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 20 quarters since.
  • Bank of America's Ginkgo Bioworks position peaked at $37M in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.